Aethlon Medical (AEMD)

$0.35 +0.00 (0.31%)
Market Cap 5.35M
Revenue (ttm) 0.00
Net Income (ttm) -12.21M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 99,900
Avg Vol 400,978
Day's Range N/A - N/A
Shares Out 14.46M
Stochastic %K 17%
Beta 1.71
Analysts Sell
Price Target $3.88

Latest News on AEMD

Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal

Mar 10, 2025, 8:01 AM EDT - 4 weeks ago

Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal

Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025

Feb 13, 2025, 8:01 AM EST - 7 weeks ago

Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025

Aethlon Medical, Inc. (AEMD) Q3 2025 Earnings Call Transcript

Feb 12, 2025, 8:11 PM EST - 7 weeks ago

Aethlon Medical, Inc. (AEMD) Q3 2025 Earnings Call Transcript

Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update

Feb 12, 2025, 4:15 PM EST - 7 weeks ago

Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025

Feb 5, 2025, 8:01 AM EST - 2 months ago

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025

Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial

Jan 29, 2025, 8:01 AM EST - 2 months ago

Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial

Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu

Dec 20, 2024, 8:01 AM EST - 3 months ago

Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu

Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally

Nov 14, 2024, 8:00 AM EST - 5 months ago

Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally

Aethlon Medical, Inc. (AEMD) Q2 2025 Earnings Call Transcript

Nov 13, 2024, 7:58 PM EST - 5 months ago

Aethlon Medical, Inc. (AEMD) Q2 2025 Earnings Call Transcript

Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update

Nov 13, 2024, 4:15 PM EST - 5 months ago

Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update

Innovative Medical Technology Advances with First Patient Enrollments

Nov 12, 2024, 8:00 AM EST - 5 months ago

Innovative Medical Technology Advances with First Patient Enrollments

Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia

Nov 11, 2024, 8:01 AM EST - 5 months ago

Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024

Nov 6, 2024, 8:01 AM EST - 5 months ago

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024

Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit

Oct 8, 2024, 8:01 AM EDT - 6 months ago

Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit

Immunotherapy Clinical Trials - A New Approach to Treating Cancer

Sep 19, 2024, 10:00 AM EDT - 7 months ago

Immunotherapy Clinical Trials - A New Approach to Treating Cancer

Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India

Sep 19, 2024, 8:01 AM EDT - 7 months ago

Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India

Aethlon Medical to Present at Virtual Investor Conferences in September

Sep 17, 2024, 8:01 AM EDT - 7 months ago

Aethlon Medical to Present at Virtual Investor Conferences in September

Innovation Driving Cancer's Solid Tumors Market

Sep 17, 2024, 7:30 AM EDT - 7 months ago

Innovation Driving Cancer's Solid Tumors Market

Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial

Sep 16, 2024, 8:01 AM EDT - 7 months ago

Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial

Aethlon Medical to Present at the Life Sciences Investor Forum September 19th

Sep 13, 2024, 8:35 AM EDT - 7 months ago

Aethlon Medical to Present at the Life Sciences Investor Forum September 19th

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys

Aug 27, 2024, 8:01 AM EDT - 7 months ago

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys

Aethlon Medical, Inc. (AEMD) Q1 2025 Earnings Call Transcript

Aug 14, 2024, 6:45 PM EDT - 8 months ago

Aethlon Medical, Inc. (AEMD) Q1 2025 Earnings Call Transcript

Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update

Aug 14, 2024, 4:15 PM EDT - 8 months ago

Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update

The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors

Aug 12, 2024, 9:01 AM EDT - 8 months ago

The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors

Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer Trial

Aug 12, 2024, 8:01 AM EDT - 8 months ago

Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer Trial

Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024

Aug 6, 2024, 9:12 AM EDT - 8 months ago

Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024

Aethlon Medical, Inc. (AEMD) Q4 2024 Earnings Call Transcript

Jun 27, 2024, 6:37 PM EDT - 10 months ago

Aethlon Medical, Inc. (AEMD) Q4 2024 Earnings Call Transcript

Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update

Jun 27, 2024, 4:15 PM EDT - 10 months ago

Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024

Jun 21, 2024, 8:01 AM EDT - 10 months ago

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024

What's Next in Treatments for Cancer Patients with Solid Tumors?

Jun 20, 2024, 7:00 AM EDT - 10 months ago

What's Next in Treatments for Cancer Patients with Solid Tumors?

Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial

Jun 18, 2024, 8:01 AM EDT - 10 months ago

Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial

The Hunt for Virus Treatments Continues Post Covid-19

Jun 7, 2024, 8:00 AM EDT - 10 months ago

The Hunt for Virus Treatments Continues Post Covid-19

Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVID

Jun 3, 2024, 9:05 AM EDT - 11 months ago

Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVID

Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies

Jun 3, 2024, 8:01 AM EDT - 11 months ago

Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies

Aethlon Medical Announces Pricing of $4.7 Million Public Offering

May 15, 2024, 9:15 AM EDT - 11 months ago

Aethlon Medical Announces Pricing of $4.7 Million Public Offering

Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma

May 10, 2024, 8:01 AM EDT - 11 months ago

Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma

Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices

Feb 21, 2024, 8:01 AM EST - 1 year ago

Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices

Aethlon Medical, Inc. (AEMD) Q3 2024 Earnings Call Transcript

Feb 14, 2024, 9:17 PM EST - 1 year ago

Aethlon Medical, Inc. (AEMD) Q3 2024 Earnings Call Transcript

Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update

Feb 14, 2024, 4:15 PM EST - 1 year ago

Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024

Feb 7, 2024, 8:00 AM EST - 1 year ago

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024

Aethlon Medical, Inc. (AEMD) Q2 2024 Earnings Call Transcript

Nov 14, 2023, 10:01 PM EST - 1 year ago

Aethlon Medical, Inc. (AEMD) Q2 2024 Earnings Call Transcript

Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update

Nov 14, 2023, 4:15 PM EST - 1 year ago

Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update

Aethlon Medical Announces Appointment of James B. Frakes, M.B.A.

Nov 13, 2023, 8:01 AM EST - 1 year ago

Aethlon Medical Announces Appointment of James B. Frakes, M.B.A.

Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023

Nov 6, 2023, 8:01 AM EST - 1 year ago

Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023

Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in Oncology

Oct 10, 2023, 8:01 AM EDT - 1 year ago

Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in Oncology

Aethlon Announces Reverse Stock Split

Oct 4, 2023, 8:01 AM EDT - 1 year ago

Aethlon Announces Reverse Stock Split

Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Aug 30, 2023, 8:01 AM EDT - 1 year ago

Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Aethlon Medical, Inc. (AEMD) Q1 2024 Earnings Call Transcript

Aug 10, 2023, 9:17 PM EDT - 1 year ago

Aethlon Medical, Inc. (AEMD) Q1 2024 Earnings Call Transcript

Aethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate Update

Aug 10, 2023, 4:15 PM EDT - 1 year ago

Aethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate Update

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 10, 2023

Aug 3, 2023, 8:01 AM EDT - 1 year ago

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 10, 2023